Kammas World

Hyderabad March 29, 2011, Natco Pharma’s (V C Nannapaneni, Chairman & MD) a nti-cancer drug, NRC-AN-019, has received ‘Orphan Drug’ designation from the US Food and Drug Administration (USFDA) for three indications — glioma (brain tumour), pancreatic cancer and chronic myelogenous leukemia. “It is for the first time that an Indian company’s drug is designated as orphan drug by the USFDA for three indications, ” Natco said in a statement today. Orphan drug designation is given by the USFDA for rare diseases that affect less than 200,000 patients in the USA. Since the market for drugs intended to treat rare diseases is small, the USFDA extends special incentives to companies involved in the discovery and development of such drugs. The incentives, according to the Hyderabad-based company, include a seven-year marketing exclusivity, specific tax credits and waiver of prescription drug user fee, which is about $1.5 million per indication. Special grants and benefits to defray the costs ...

Chicago: Hearing impairment is a very common ailment. In milder cases, the impairment goes unnoticed. But continuous neglect of hearing impairment leads to serious hearing loss. Hearing loss, if remains untreated, progressively increases. Surgery is one option, but not for most cases of age-related hearing loss. Also in some cases of hearing loss, a surgery cannot be performed. That is why doctors recommend the use of hearing aid if a person is diagnosed with hearing loss. Because of the high cost of hearing aids prevailing in the market, most patients with hearing impairment do not buy them and suffer silently. But now there is a hope for such patients. Dr. Sreekant Cherukuri , a Chicago-based otolaryngologist, who is an expert in treating hearing loss, has created a very high- quality and sensitive hearing aid with an affordable cost that has raised hope for all middle and low-income patients with hearing loss. In an interview Dr. Sreekant Cherukuri, who is an expert in treating e...

7Seas Entertainment Limited (Lingamaneni Maruti Sankar, Managing Director) has bagged the prestigious FICCI-BAF (Best of Animation Frames) award for its 'The Dark Man' game under the 'Best Online Game' category. The Dark Man, an online game developed by 7Seas enhances concentration and logical thinking of the gamers. The game is available at online gaming portal www.onlinerealgames.com . 7Seas' online game 'Mouse Maze' had bagged the FICCI-BAF award under the 'Best Online Game' category for 2008. The award was received by Mr.Lingamaneni Maruti Sanker - MD of 7Seas Entertainment at the 2 day FICCI FRAMES-2011 event that concluded on March 24, 2011. FICCI (BAF)-2011 awards had received 400 entries in 15 categories from 10 countries.

Chandigarh, March 25: Girls Under-12 (Singles) Pranjala Yadlapalli (AP) bt Snehal Umesh Mane (MAH) 6-0, 6-1 won the CLTA-AITA Super Series Tennis Tournament title. Girls Under -12 (Doubles): Nidhi Surapani (AP) and Pranjala Yadlapalli (AP) bt Prabhuti Singhania (MAH) and Victoria Chahal (HAR) 6-4, 6-4 to clinch the title.

Lanco Infratech, (Lagadapati Madhusudhana Rao, Chairman) with interests in power generation, construction, infrastructure and property development, said that it has emerged the largest independent power producer in India with an installed capacity of 3,292 mw. The company has achieved this through synchronising the 600 mw unit of Lanco Anpara Power, a special purpose vehicle implementing the power project of 1,200 mw in two tranches in Uttar Pradesh. Lanco Infratech now has 5,953 mw of power projects under various stages of construction and 4,470 mw of power projects under development. Anpara is a pithead project with coal-mines 25 km away with an existing system of transportation of coal in railway wagons. Lanco group executive chairman L Madhusudhan Rao said the synchronisation of Anpara’s 600 mw unit proves the company’s capabilities to execute projects “no matter how hard the challenges are.” Rao said the company has grown its installed capacity to 3,292 mw from 500 mw in three ye...

Sairam Atluri , MD (Tri-State Spine Care, Cincinnati). Dr. Atluri is the director of the Tri-State Spine Care Institute in Cincinnati and has served as vice president of the Ohio Chapter of the American Society of Interventional Pain Physicians. He was the primary author of the ASIPP guidelines for opioid use in chronic pain and a secondary author of the guidelines for interventional therapy for low back pain. He is also a Fellow of Interventional Pain Practice from the World Institute of Pain and author of a pain management textbook. In addition to his practice, Dr. Atluri has published on the screening for opioid abuse in chronic pain and presented his research at the annual meeting for the American Pain Society . Dr. Atluri has been named one of Cincinnati Magazine's top physicians. Dr. Atluri earned his medical degree from Osmania Medical College in India and completed his residency at Cincinnati's University Hospital in anesthesia and pain management.

Dallas, TEXAS: CMSN 8th grade student Chaithra Katamneni won the North Texas PGA (NTPGA) Tour Championship for 2010. This 2-day golf tournament was held at Stonebridge Country Club in McKinney, Texas. Chaithra scored 76 and 73 to win by 6 strokes under her nearest competitor. After 7 months of competition in various tournaments during 2010, the top players from East, West and North Texas had to qualify and then be invited to play in this prestigious tournament. Chaithra is 13 years old and is the youngest winner to have won the 15-18 year old girls division in this championship’s history.